Pendrea Bio
Phase 1PendreaBio is a clinical stage biopharmaceutical company pursuing two distinct approaches to the treatment of cancer.
Founded
2022
Focus
Drug Delivery
About
PendreaBio is a clinical stage biopharmaceutical company pursuing two distinct approaches to the treatment of cancer.
Funding History
1Total raised: $5.2M
Seed$5.2MUndisclosedJun 15, 2022
Company Info
TypePrivate
Founded2022
LocationCambridge, United States
StagePhase 1
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile